Publications

Optimal intrapartum care in the twenty-first century

Optimal intrapartum care in the twenty-first century

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum haemorrhage

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum haemorrhage

Procurement and Supply of Quality-Assured Maternal, Newborn, and Child Health Commodities

Procurement and Supply of Quality-Assured Maternal, Newborn, and Child Health Commodities

Current research on carbetocin and implications for prevention of postpartum haemorrhage

Current research on carbetocin and implications for prevention of postpartum haemorrhage

WHO Drug Information Quality of Medicines: Quality of Misoprostol Products

WHO Drug Information Quality of Medicines: Quality of Misoprostol Products

Business Case: Investing in Production of High-Quality Oxytocin for Low-Resource Settings

Business Case: Investing in Production of High-Quality Oxytocin for Low-Resource Settings

Business Case: Investing in Production of High-Quality Misoprostol for Low-Resource Settings

Business Case: Investing in Production of High-Quality Misoprostol for Low-Resource Settings

Business Case: Investing in Production of High-Quality Magnesium Sulfate for Low-Resource Settings

Business Case: Investing in Production of High-Quality Magnesium Sulfate for Low-Resource Settings

In Focus: The Quality of Reproductive Health Medicines Programme

In Focus: The Quality of Reproductive Health Medicines Programme

Medicines for Reproductive Health: ensuring access to quality assured products

Medicines for Reproductive Health: ensuring access to quality assured products

Frequently Asked Questions on the Prequalification of Medicines for Reproductive Health – Chinese

Frequently Asked Questions on the Prequalification of Medicines for Reproductive Health – Chinese

Frequently Asked Questions on the Prequalification of Medicines for Reproductive Health

Frequently Asked Questions on the Prequalification of Medicines for Reproductive Health